| |
Effect (percentage of cases prevented)a
|
Cost (AUD)
|
ICER
|
|---|
|
Control
|
Intervention
|
Difference
|
Control
|
Intervention
|
Difference
|
Per case prevented
|
|---|
|
Base-case
|
11.78
|
9.53
|
2.25
|
$8248
|
$8281
|
$33
|
$1470
|
|
BMI subgroup analysis
|
|
Up to 25
|
8.71
|
7.00
|
1.71
|
$7891
|
$7965
|
$74
|
$4314
|
|
25 up to 30
|
12.44
|
10.07
|
2.37
|
$8388
|
$8411
|
$23
|
$974
|
|
30 plus
|
18.87
|
15.38
|
3.49
|
$9023
|
$8974
|
− $49
|
Dominant (cost saving)
|
|
25 plus
|
15.25
|
12.39
|
2.86
|
$8667
|
$8657
|
− $10
|
Dominant (cost saving)
|
|
Scenario analysisb
|
11.78
|
9.57
|
2.21
|
$8248
|
$8283
|
$35
|
$1582
|
- AUD Australian dollars, ICER incremental cost-effectiveness ratio, BMI body mass index
- aFor gestational diabetes and/or hypertensive disease
- bThe risk ratio for the health states of gestational diabetes and hypertensive disease in pregnancy is set to risk ratio for hypertensive disease in pregnancy